Colistin therapy for multidrug-resistant Gram-negative infection: clinical outcome and risk factors

Infection. 2013 Dec;41(6):1195-8. doi: 10.1007/s15010-013-0522-z. Epub 2013 Sep 15.

Authors

Y H Jun¹, S J Jeun, S H Kang, H J Choi

Affiliation

¹ Division of Infectious Disease, Department of Internal Medicine, Ewha Womans University, Mokdong Hospital, 911-1 MokDong, Yangcheon-Ku, Seoul, Korea.

PMID: 24037723
DOI: 10.1007/s15010-013-0522-z

No abstract available

MeSH terms

Aged
Analysis of Variance
Anti-Bacterial Agents / adverse effects
Anti-Bacterial Agents / therapeutic use*
Colistin / adverse effects
Colistin / therapeutic use*
Cross Infection / drug therapy*
Drug Resistance, Multiple, Bacterial
Female
Gram-Negative Bacterial Infections / drug therapy*
Hospitalization
Humans
Male
Middle Aged
Retrospective Studies
Risk Factors
Treatment Outcome

Substances

Anti-Bacterial Agents
Colistin